US Stock MarketDetailed Quotes
CRBU Caribou Biosciences
- 3.760
- -0.090-2.34%
Close Apr 25 16:00 ET
- 3.770
- +0.010+0.27%
Post 18:45 ET
339.58MMarket Cap-2724P/E (TTM)
3.840High3.710Low1.63MVolume3.800Open3.850Pre Close6.16MTurnover2.38%Turnover RatioLossP/E (Static)90.31MShares8.59052wk High0.92P/B257.49MFloat Cap3.44052wk Low--Dividend TTM68.48MShs Float32.645Historical High--Div YieldTTM3.38%Amplitude3.440Historical Low3.772Avg Price1Lot Size
About Caribou Biosciences Company
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Company Profile
SymbolCRBU
Company NameCaribou Biosciences
Listing DateJul 23, 2021
Issue Price16.00
Founded2011
CEODr. Rachel Haurwitz, PhD
MarketNASDAQ
Employees158
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2929 7th Street,Suite 105
CityBerkeley
ProvinceCalifornia
CountryUnited States of America
Zip Code94710
Phone1-510-982-6030
Websitehttp://www.cariboubio.com
Company Executives
- Name
- Position
- Salary
- Dr. Rachel Haurwitz, PhD
- President, Chief Executive Officer and Director
- 833.47K
- Syed Ali-aamir Rizvi, M.D.
- Chief Medical Officer
- 2.39M
- Ruhi Ahmad Khan
- Chief Business Officer
- 1.04M
- Dr. Steven B. Kanner
- Chief Scientific Officer
- --
- Jason V. O’Byrne
- Chief Financial Officer and Principal Accounting Officer
- --
- Barbara G. McClung
- Chief Legal Officer and Corporate Secretary
- 485.25K
- Andrew L. Guggenhime
- Chairman of the Board
- 95.40K
- Dr. Scott Braunstein, M.D.
- Independent Director
- 61.38K
- Dr. Dara Richardson-Heron
- Independent Director
- 43.75K
- Ran Zheng
- Independent Director
- 55.77K
- David L. Johnson, C.P.A.
- Independent Director
- 283.61K
- Dr. Natalie Sacks
- Independent Director
- 72.32K
- Dr. Nancy C. Whiting, Pharm.D.
- Independent Director
- 69.47K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
